These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 29892304

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Toward a structure-based comprehension of the lectin pathway of complement.
    Kjaer TR, Thiel S, Andersen GR.
    Mol Immunol; 2013 Dec; 56(4):413-22. PubMed ID: 23911397
    [Abstract] [Full Text] [Related]

  • 24. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
    Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S.
    Arthritis Rheum; 2011 Apr; 63(4):1076-85. PubMed ID: 21452327
    [Abstract] [Full Text] [Related]

  • 25. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.
    Skjoedt MO, Palarasah Y, Munthe-Fog L, Jie Ma Y, Weiss G, Skjodt K, Koch C, Garred P.
    Immunobiology; 2010 Nov; 215(11):921-31. PubMed ID: 19939495
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.
    J Immunol; 2001 May 15; 166(10):6444-51. PubMed ID: 11342671
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation.
    Kusakari K, Machida T, Ishida Y, Omori T, Suzuki T, Sekimata M, Wada I, Fujita T, Sekine H.
    Front Immunol; 2022 May 15; 13():907023. PubMed ID: 36052069
    [Abstract] [Full Text] [Related]

  • 31. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
    Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T.
    Nephrol Dial Transplant; 1998 Aug 15; 13(8):1984-90. PubMed ID: 9719152
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
    Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC.
    Int Immunol; 2007 Feb 15; 19(2):141-9. PubMed ID: 17182967
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.
    Sekine H, Ruiz P, Gilkeson GS, Tomlinson S.
    Mol Immunol; 2011 Oct 15; 49(1-2):317-23. PubMed ID: 22000720
    [Abstract] [Full Text] [Related]

  • 36. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
    Kozarcanin H, Lood C, Munthe-Fog L, Sandholm K, Hamad OA, Bengtsson AA, Skjoedt MO, Huber-Lang M, Garred P, Ekdahl KN, Nilsson B.
    J Thromb Haemost; 2016 Mar 15; 14(3):531-45. PubMed ID: 26614707
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.
    Banda NK, Takahashi M, Takahashi K, Stahl GL, Hyatt S, Glogowska M, Wiles TA, Endo Y, Fujita T, Holers VM, Arend WP.
    Mol Immunol; 2011 Oct 15; 49(1-2):281-9. PubMed ID: 21943708
    [Abstract] [Full Text] [Related]

  • 38. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication.
    Matsushita M, Endo Y, Fujita T.
    Arch Immunol Ther Exp (Warsz); 2013 Aug 15; 61(4):273-83. PubMed ID: 23563865
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
    Ruseva MM, Takahashi M, Fujita T, Pickering MC.
    Clin Exp Immunol; 2014 Apr 15; 176(1):84-92. PubMed ID: 24279761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.